SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-302705
Filing Date
2014-08-08
Accepted
2014-08-08 14:01:30
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d727126d10q.htm 10-Q 299632
2 EX-10.1 d727126dex101.htm EX-10.1 30148
3 EX-31.1 d727126dex311.htm EX-31.1 5990
4 EX-31.2 d727126dex312.htm EX-31.2 6075
5 EX-32.1 d727126dex321.htm EX-32.1 4418
6 EX-32.2 d727126dex322.htm EX-32.2 4212
  Complete submission text file 0001193125-14-302705.txt   2882849

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ccxi-20140630.xml EX-101.INS 395314
8 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20140630.xsd EX-101.SCH 27622
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20140630_cal.xml EX-101.CAL 46402
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20140630_def.xml EX-101.DEF 72740
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20140630_lab.xml EX-101.LAB 236819
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20140630_pre.xml EX-101.PRE 165334
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 141026880
SIC: 2834 Pharmaceutical Preparations